2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Breast Neoplasms
7
Neoplasms
3
Lung Neoplasms
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pleural Effusion
1
Pituitary Diseases
1
Pituitary ACTH Hypersecretion
1
Obesity
1
Myasthenia Gravis
1
Motor Activity
1
Lymphoma
1
Kidney Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Cardiotoxicity
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Adenocarcinoma of Lung
1
ACTH-Secreting Pituitary Adenoma
1
Interventions
relacorilant
3
Mifepristone
3
Corlux
3
Cabergoline
3
pasireotide
2
fimepinostat
1
corticorelin ovine
1
Tissue Banks
1
Rosiglitazone
1
Perceived Stress Scale
1
Magnetic Resonance Spectroscopy
1
Deamino Arginine Vasopressin
1
Biomarkers
1
4-amino-4'-hydroxylaminodiphenylsulfone
1
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pituitary ACTH Hypersecretion
×
Biomarkers
×
Clear all
NCT07463625
2026-03-11
PiTFET
Hospices Civils de Lyon
Recruiting
20 enrolled